Easily obtainable clinical features increase the diagnostic accuracy for latent autoimmune diabetes in adults: An evidence-based report

Primary Care Diabetes

Volumn 2, Issue 4, 2008, Pages 207-211

  Lutgens, Maurice W M D ^a   Meijer, Melanie ^a   Peeters, Babette ^a   Poulsen, Marie Louise N F ^a   Rutten, Marjet J ^a   Bots, Michiel L ^a   van der Heijden, Geert J M G ^a   Soedamah Muthu, Sabita S ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Diagnosis; Evidence based medicine; Latent autoimmune diabetes in adults; Screening

Indexed keywords

ANTIDIABETIC AGENT; AUTOANTIBODY;

ARTICLE; BLOOD; BODY MASS; DIFFERENTIAL DIAGNOSIS; DRUG EFFECT; EVIDENCE BASED MEDICINE; GLUCOSE BLOOD LEVEL; HUMAN; IMMUNOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; MIDDLE AGED; ONSET AGE; PRACTICE GUIDELINE; PREDICTION AND FORECASTING; RISK FACTOR;

AGE OF ONSET; AUTOANTIBODIES; BLOOD GLUCOSE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 1; DIAGNOSIS, DIFFERENTIAL; EVIDENCE-BASED MEDICINE; HUMANS; HYPOGLYCEMIC AGENTS; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; RISK FACTORS;

EID: 56349143667     PISSN: 17519918     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcd.2008.08.003     Document Type: Article

References (15)

1. Verge C.F., Stenger D., Bonifacio E., Colman P.G., Pilcher C., Bingley P.J., et al. Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: combinatorial Islet Autoantibody Workshop. Diabetes 47 December (12) (1998) 1857-1866
2. Genovese S., Bazzigaluppi E., Goncalves D., Ciucci A., Cavallo M.G., Purrello F., et al. Clinical phenotype and beta-cell autoimmunity in Italian patients with adult-onset diabetes. Eur. J. Endocrinol. 154 March (3) (2006) 441-447
3. Turner R., Stratton I., Horton V., Manley S., Zimmet P., Mackay I.R., et al. UKPDS, 25, autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group. Lancet 350 November 1 (9087) (1997) 1288-1293
4. Stratton I.M., Adler A.I., Neil H.A., Matthews D.R., Manley S.E., Cull C.A., et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321 August 12 (7258) (2000) 405-412
5. Fourlanos S., Perry C., Stein M.S., Stankovich J., Harrison L.C., and Colman P.G. A clinical screening tool identifies autoimmune diabetes in adults. Diab. Care 29 May (5) (2006) 970-975
6. Zinman B., Kahn S.E., Haffner S.M., O'Neill M.C., Heise M.A., and Freed M.I. Phenotypic characteristics of GAD antibody-positive recently diagnosed patients with type 2 diabetes in North America and Europe. Diabetes 53 December (12) (2004) 3193-3200
7. Lohmann T., Kellner K., Verlohren H.J., Krug J., Steindorf J., Scherbaum W.A., et al. Titre and combination of ICA and autoantibodies to glutamic acid decarboxylase discriminate two clinically distinct types of latent autoimmune diabetes in adults (LADA). Diabetologia 44 August (8) (2001) 1005-1010
8. Carlsson A., Sundkvist G., Groop L., and Tuomi T. Insulin and glucagon secretion in patients with slowly progressing autoimmune diabetes (LADA). J. Clin. Endocrinol. Metab. 85 January (1) (2000) 76-80
9. Pietropaolo M., Barinas-Mitchell E., Pietropaolo S.L., Kuller L.H., and Trucco M. Evidence of islet cell autoimmunity in elderly patients with type 2 diabetes. Diabetes 49 January (1) (2000) 32-38
10. Davis T.M., Zimmet P., Davis W.A., Bruce D.G., Fida S., and Mackay I.R. Autoantibodies to glutamic acid decarboxylase in diabetic patients from a multi-ethnic Australian community: the Fremantle Diabetes Study. Diabet. Med. 17 September (9) (2000) 667-674
11. Monge L., Bruno G., Pinach S., Grassi G., Maghenzani G., Dani F., et al. A clinically orientated approach increases the efficiency of screening for latent autoimmune diabetes in adults (LADA) in a large clinic-based cohort of patients with diabetes onset over 50 years. Diabet. Med. 21 May (5) (2004) 456-459
12. Offringa M. Introduction to Evidence-Based-Medicine-Clinical Practise Based on Evidence. 2nd ed. (2003), Bohn Stafleu van Loghem, Houten/Antwerpen (in Dutch)
13. Arikan E., Sabuncu T., Ozer E.M., and Hatemi H. The clinical characteristics of latent autoimmune diabetes in adults and its relation with chronic complications in metabolically poor controlled Turkish patients with type 2 diabetes mellitus. J. Diabet. Complications 19 September (5) (2005) 254-258
14. Castleden H.A., Shields B., Bingley P.J., Williams A.J., Sampson M., Walker M., et al. GAD antibodies in probands and their relatives in a cohort clinically selected for type 2 diabetes. Diabet. Med. 23 August (8) (2006) 834-838
15. Romkens T.E., Kusters G.C., Netea M.G., and Netten P.M. Prevalence and clinical characteristics of insulin-treated, anti-GAD-positive, type 2 diabetic subjects in an outpatient clinical department of a Dutch teaching hospital. Neth. J. Med. 64 April (4) (2006) 114-118